These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8354241)

  • 1. Acetylator phenotyping via analysis of four caffeine metabolites in human urine by micellar electrokinetic capillary chromatography with multiwavelength detection.
    Guo R; Thormann W
    Electrophoresis; 1993; 14(5-6):547-53. PubMed ID: 8354241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
    Nyéki A; Buclin T; Biollaz J; Decosterd LA
    Br J Clin Pharmacol; 2003 Jan; 55(1):62-7. PubMed ID: 12534641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.
    Nyéki A; Biollaz J; Kesselring UW; Décosterd LA
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):73-84. PubMed ID: 11393735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.
    Tang BK; Kadar D; Qian L; Iriah J; Yip J; Kalow W
    Clin Pharmacol Ther; 1991 Jun; 49(6):648-57. PubMed ID: 2060254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
    Jetter A; Kinzig M; Rodamer M; Tomalik-Scharte D; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2009 Apr; 65(4):411-7. PubMed ID: 19082994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
    Krul C; Hageman G
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(1):27-34. PubMed ID: 9653923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping.
    Wong P; Banerjee K; Massengill J; Nowell S; Lang N; Leyland-Jones B
    J Immunol Methods; 2001 May; 251(1-2):1-9. PubMed ID: 11292476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
    Relling MV; Lin JS; Ayers GD; Evans WE
    Clin Pharmacol Ther; 1992 Dec; 52(6):643-58. PubMed ID: 1458773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
    Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry.
    Schneider H; Ma L; Glatt H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(2):227-37. PubMed ID: 12742114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry.
    Weimann A; Sabroe M; Poulsen HE
    J Mass Spectrom; 2005 Mar; 40(3):307-16. PubMed ID: 15685651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine.
    Wong P; Villeneuve G; Tessier V; Banerjee K; Nedev H; Jean-Claude BJ; Leyland-Jones B
    J Pharm Biomed Anal; 2002 May; 28(3-4):693-700. PubMed ID: 12008149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine acetylator phenotyping during maturation in infants.
    Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
    Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry.
    Baud-Camus F; Marquet P; Soursac M; Davrinche C; Farinotti R
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):55-63. PubMed ID: 11522066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human N-acetylation genotype determination with urinary caffeine metabolites.
    Kilbane AJ; Silbart LK; Manis M; Beitins IZ; Weber WW
    Clin Pharmacol Ther; 1990 Apr; 47(4):470-7. PubMed ID: 2328555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures.
    Caslavska J; Hufschmid E; Theurillat R; Desiderio C; Wolfisberg H; Thormann W
    J Chromatogr B Biomed Appl; 1994 Jun; 656(1):219-31. PubMed ID: 7952033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.